Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,226 | $6,026 | $7,462 | $7,273 |
| - Cash | $784 | $467 | $150 | $193 |
| + Debt | $537 | $520 | $6 | $0 |
| Enterprise Value | $10,979 | $6,080 | $7,317 | $7,080 |
| Revenue | $2,519 | $1,568 | $1,023 | $958 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Gross Profit | $1,484 | $1,020 | $759 | $719 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| EBITDA | $474 | $347 | $305 | $265 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |
| Net Income | $103 | $123 | $190 | $149 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| % Growth | -29.9% | -42.2% | 28.5% | – |
| Operating Cash Flow | $521 | $243 | $178 | $276 |
| Capital Expenditures | -$115 | -$78 | -$74 | -$57 |
| Free Cash Flow | $405 | $165 | $104 | $219 |